3. Acutus Medical
Venture capital raised: $70 million, $100 million
Acutus Medical raised $70 million in Q2 last year in a debt offering of a line of credit and raised $100 million in Q2 in a Series D funding round, according to the MoneyTree report.
Acutus Medical says it is developing safe, efficacious and cost-effective solutions for people who have complex cardiac arrhythmias. The company currently offers minimally invasive diagnostic mapping of complex arrhythmias to allow doctors to optimize treatments and expand ablation.
The company in June said it reeled in $170 million in financing from its Series D with a new credit line for its cardiac mapping technology. The Series D funded the company with $100 million and a $70 million credit facility. Both were earmarked for commercialization and business development.
Acutus Medical won CE Mark and FDA clearance for its second-generation AcQMap system in April last year. The system is designed to detect and display standard voltage-based and higher resolution charge-source maps and is able to generate real-time, 3D images of the heart chamber using ultrasound.
In May, Acutus Medical purchased Rhythm Xience for an undisclosed amount. Rhythm Xience made a line of transeptal crossing and steerable introducer systems that were all FDA-cleared.